News

Shares in drug company MediGene have risen sharply following rumours that Pfizer is eyeing the German spin-out as a takeover target.

Scientists and engineers from Germany, Belgium, the UK and the US scooped the top prizes in the European Innovator of the Year 2008 competition.

Microsoft start-up programme Idées is going local in Lille – a prelude to going local globally.

Biotechnology and risk have always been synonymous. But now those risks are evolving and growing, exposing companies to fresh hazards.